Drug Pricing Transparency
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed House
- To Governor
- Became Law
Overview
This amendment aims to increase transparency regarding drug pricing within the Commonwealth of Massachusetts. Specifically, it requires the Department of Public Health to collect and publicly report data on the prices paid for prescription drugs by the state. This data will be used to analyze and potentially address high drug costs. The amendment is attached to an appropriations bill for the fiscal year 2027.
Key provisions
- Requires the Department of Public Health to collect data on prescription drug prices paid by the state.
- Mandates the public reporting of this drug pricing data.
- Focuses on analyzing and addressing high drug costs within Massachusetts.
- The amendment is linked to the fiscal year 2027 appropriations bill.
Who is affected
- Massachusetts residents
- The Department of Public Health
- Prescription drug manufacturers
- State government agencies
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsor
Michael F. Rush
Cosponsors
Michael F. Rush
Michael O. Moore
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours